The Chinese AI lab may have just found a way to train advanced LLMs in a manner that's practical and scalable, even for more cash-strapped developers.
At the 2026 JP Morgan Healthcare Conference, CytoReason unveiled LINA, an AI agent designed to support pharmaceutical research and development.
Bernice Asantewaa Kyere on modeling that immediately caught my attention. The paper titled “A Critical Examination of Transformational Leadership in Implementing Flipped Classrooms for Mathematics ...
The recent creation of the NIH Office of Research Integrity, Validation, and Adoption of New Approach Methodologies (ORIVA) is more than just an administrative shift. It represents a historic ...
In the same vein as weather forecast models that predict developing storms, researchers have now developed a method to predict the cell activity in tissues over time. The new software combines ...
Researchers have reported a sample-prior-based approach to point spread function decoupling that improves system ...
That challenge is examined in the study Towards Eco-Friendly Cybersecurity: Machine Learning-Based Anomaly Detection with ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the crucial debate about whether ...
Subsurface reservoir engineering has become increasingly pivotal as the world intensifies its focus on sustainable energy systems and effective resource ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback